Lymphedema — CPB 0069 | AETNA Coverage Update

Aetna modified CPB 0069 for lymphedema coverage, effective February 27, 2026. Here's what billing teams need to know before submitting claims.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0069 governing lymphedema treatment — including complex decongestive physiotherapy (CDP), pneumatic compression devices, and surgical interventions. The CPB 0069 Aetna system update touches codes across a wide range, including CPT 0358T for bioelectrical impedance analysis, CPT 1019T for lymphovenous bypass, and a large set of tissue transfer codes in the 14000 series. If your practice bills for lymphedema pumps, manual lymphatic drainage, or surgical lymphedema treatment, this coverage policy change affects your reimbursement.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Lymphedema — CPB 0069
Policy Code	CPB 0069
Change Type	Modified
Effective Date	February 27, 2026
Impact Level	High
Specialties Affected	Physical therapy, occupational therapy, vascular surgery, lymphedema clinics, DME suppliers, oncology rehab
Key Action	Audit documentation for the four-week conservative therapy trial before billing pneumatic compression devices — missing trial records are the most common reason for claim denial

---

Aetna Lymphedema Coverage Criteria and Medical Necessity Requirements 2026

This is a policy with real teeth. Aetna's medical necessity standards for lymphedema billing are specific, sequential, and documentation-heavy. If your team doesn't have the right records in the chart before the claim goes out, you will get denied.

Complex Decongestive Physiotherapy (CDP)

Aetna covers CDP — also called complete decongestive therapy or manual lymphatic drainage — when two conditions are both met. First, the member must have at least one of these: evidence of ulceration due to lymphedema, intractable lymphedema of the extremities unrelieved by elevation, or at least one prior hospital admission for complications like cellulitis or ulceration.

Second, the member must show a documented record of compliance. The member or their caregiver also must be capable of following CDP instructions. Both boxes must be checked. One without the other won't get you covered.

Pneumatic Compression Devices — Non-Calibrated Gradient Devices

This is where lymphedema billing gets complicated — and where most denials happen. For non-segmented or segmented pneumatic compression devices without manual pressure control in each chamber (your standard home pump), Aetna's coverage policy requires all of the following.

The member must have a confirmed lymphedema diagnosis. The lymphedema must be chronic and severe, proven by at least one of these documented clinical findings: marked hyperkeratosis with hyperplasia and hyperpigmentation, papillomatosis cutis lymphostatica, elephantiasis deformity, or skin breakdown with persisting lymphorrhea. Alternatively, detailed measurements over time confirm persistence along with a documented likely etiology.

That persistence alone isn't enough. The lymphedema must also be unresponsive to a full four-week conservative therapy trial. That trial must include all three of the following: regular use of a compression bandage or garment with adequate graduated compression, regular exercise, and limb elevation. When available, manual lymphatic drainage and appropriate medication for concurrent congestive failure are also components.

Here's the catch most teams miss: if the patient improves during the trial, the pump is not medically necessary. The trial continues. Only when no significant improvement occurs in the most recent four weeks — and the severity criteria are still met — does the device qualify. Reassessments during the trial must use detailed measurements at the same anatomic landmarks, obtained in the same manner, at intervals at least one week apart.

Document this with exact measurements, dates, and landmarks. Vague notes won't hold up on audit.

Prior Authorization and Reimbursement Exposure

Whether prior authorization is required for specific codes under this policy varies by plan. Check the member's specific plan documents. That said, the medical necessity documentation standards in this coverage policy function as a de facto prior auth checklist — if you can't satisfy them before billing, you won't satisfy them on appeal either. Talk to your compliance officer if you're unsure how your Aetna plan mix handles prior auth for durable medical equipment under CPB 0069.

---

Aetna Lymphedema Exclusions and Non-Covered Indications

Aetna classifies several lymphedema-adjacent treatments as experimental or investigational. These appear in the policy's code groupings and represent real claim denial risk if billed without understanding their status.

CPT 0232T (platelet rich plasma injection) falls into an experimental grouping under this policy. CPT 0481T (autologous white blood cell concentrate injection) is similarly classified. These are not covered for lymphedema indications under CPB 0069.

CPT 0358T for bioelectrical impedance analysis — whole body composition assessment — also appears in the experimental/investigational grouping. This matters for practices that use bioimpedance to assess lymphedema severity. Billing this for a lymphedema diagnosis under Aetna carries high denial risk as of the February 27, 2026 effective date.

If your practice uses any of these codes as part of a lymphedema management protocol, pull those claims before they go out. This is the kind of pattern that generates payer audits, not just individual denials.

---

Coverage Indications at a Glance

---

Aetna Lymphedema Billing Guidelines and Action Items 2026

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Lymphedema Under CPB 0069

The code set under this policy is broad — 389 CPT codes and 134 HCPCS codes in total. Below are the key codes from the policy data with confirmed descriptions.

Covered CPT Codes (When Selection Criteria Are Met)

Note: The full policy lists 389 CPT codes and 134 HCPCS codes. The tissue transfer series continues beyond what is shown here. Access the complete code list at app.payerpolicy.org/p/aetna/0069.

Not Covered / Experimental Codes

Code	Type	Description	Reason Copy
0232T	CPT	Injection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation	Classified as experimental/investigational under CPB 0069
0358T	CPT	Bioelectrical impedance analysis whole body composition assessment, with interpretation and report	Classified as experimental/investigational under CPB 0069
0481T	CPT	Injection(s), autologous white blood cell concentrate (autologous protein solution), any site	Classified as experimental/investigational under CPB 0069

Key ICD-10-CM Diagnosis Codes

The policy references 13 ICD-10-CM codes. The policy data provided does not include the full code descriptions in this extract. Pull the complete ICD-10 list from the full policy at app.payerpolicy.org/p/aetna/0069 to verify which lymphedema diagnosis codes Aetna recognizes under CPB 0069. Your billing team should map these against your current charge capture to catch any mismatches before claims drop.

---